v3.26.1
Revenue - Summary of Revenue Recognized, Transaction Price as a Result of Recognition of Milestones, and Estimated Revenue Expected to Be Recognized (Parenthetical) (Details)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
USD ($)
Milestones
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
Disaggregation of Revenue [Line Items]      
Revenue $ 26,523 $ 219  
Novo Collaboration Agreement Member      
Disaggregation of Revenue [Line Items]      
One-time non-refundable upfront payment received $ 195,000    
Number of milestones probable to achievement | Milestones 2    
Variable consideration $ 94,000    
Revenue [1] 71,900    
Novo Collaboration Agreement Member | R&D Programs and Manufacturing Services      
Disaggregation of Revenue [Line Items]      
One-time non-refundable upfront payment received 153,800    
Variable consideration 10,300   $ 18,600
Novo Collaboration Agreement Member | Material Right      
Disaggregation of Revenue [Line Items]      
One-time non-refundable upfront payment received 41,200    
Novo Collaboration Agreement Member | R&D Programs      
Disaggregation of Revenue [Line Items]      
One-time non-refundable upfront payment received 15,700   $ 26,800
Novo Collaboration Agreement Member | Collaboration milestones      
Disaggregation of Revenue [Line Items]      
One-time non-refundable upfront payment received 500    
Novo Collaboration Agreement Member | Discovery Research Milestones      
Disaggregation of Revenue [Line Items]      
Variable consideration $ 2,000    
[1] For the three months ended March 31, 2026, the Company recognized revenue of $26.5 million, which was comprised of $10.3 million variable consideration related to research services for the four R&D Programs and manufacturing services, $15.7 million recognition of deferred revenue for the one-time, non-refundable upfront payment, and $0.5 million milestone revenue recognized on the two milestones discussed above. The Company recognized $26.8 million of the one-time, non-refundable upfront payment and $18.6 million variable considerations related to research services for the four R&D Programs and manufacturing services during the year ended December 31, 2025.